HCA Healthcare (NYSE:HCA) Receives “Overweight” Rating from Cantor Fitzgerald

HCA Healthcare (NYSE:HCA)‘s stock had its “overweight” rating reaffirmed by equities research analysts at Cantor Fitzgerald in a report issued on Tuesday, Benzinga reports. They presently have a $392.00 price target on the stock. Cantor Fitzgerald’s price target indicates a potential downside of 3.18% from the stock’s current price.

HCA has been the subject of several other reports. Wells Fargo & Company increased their price objective on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 30th. UBS Group lifted their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Oppenheimer raised their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price on the stock. Finally, Truist Financial increased their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Five investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

HCA Healthcare Stock Down 0.4 %

NYSE:HCA traded down $1.57 during trading hours on Tuesday, reaching $404.86. The company had a trading volume of 159,149 shares, compared to its average volume of 1,130,916. The firm has a market cap of $106.04 billion, a price-to-earnings ratio of 20.18, a P/E/G ratio of 1.52 and a beta of 1.67. The business’s 50-day simple moving average is $380.53 and its two-hundred day simple moving average is $343.58. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare has a twelve month low of $215.96 and a twelve month high of $409.42.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same quarter in the prior year, the company earned $4.29 earnings per share. The company’s quarterly revenue was up 10.3% on a year-over-year basis. On average, equities analysts expect that HCA Healthcare will post 22.46 earnings per share for the current year.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock valued at $6,407,273 in the last quarter. 1.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On HCA Healthcare

Several institutional investors have recently made changes to their positions in the company. Steward Partners Investment Advisory LLC increased its position in shares of HCA Healthcare by 49.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,993 shares of the company’s stock worth $539,000 after acquiring an additional 655 shares during the period. Stifel Financial Corp increased its stake in shares of HCA Healthcare by 19.8% during the fourth quarter. Stifel Financial Corp now owns 63,429 shares of the company’s stock valued at $17,180,000 after buying an additional 10,491 shares during the period. The Manufacturers Life Insurance Company grew its holdings in HCA Healthcare by 2.1% during the 4th quarter. The Manufacturers Life Insurance Company now owns 165,106 shares of the company’s stock worth $44,691,000 after acquiring an additional 3,441 shares in the last quarter. NEOS Investment Management LLC lifted its position in shares of HCA Healthcare by 25.8% in the 4th quarter. NEOS Investment Management LLC now owns 2,808 shares of the company’s stock worth $760,000 after purchasing an additional 576 shares during the period. Finally, CIBC Private Wealth Group LLC raised its stake in HCA Healthcare by 29.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 22,756 shares of the company’s stock worth $6,160,000 after buying an additional 5,244 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.